(Q45116933)

9 December 2017

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). (English)

1 reference

9 December 2017

2

Yataro Daigo

1 reference

9 December 2017

1

Soji Kakiuchi

1 reference

9 December 2017

Nobuhisa Ishikawa

3

1 reference

9 December 2017

Chiyuki Furukawa

4

1 reference

9 December 2017

Tatsuhiko Tsunoda

5

1 reference

9 December 2017

Seiji Yano

6

1 reference

9 December 2017

Kazuhiko Nakagawa

7

1 reference

9 December 2017

Takashi Tsuruo

8

1 reference

9 December 2017

Nobuoki Kohno

9

1 reference

9 December 2017

Masahiro Fukuoka

10

1 reference

9 December 2017

Saburo Sone

11

1 reference

9 December 2017

Yusuke Nakamura

12

1 reference

9 December 2017

20 October 2004

1 reference

9 December 2017

Human Molecular Genetics

1 reference

9 December 2017

13

1 reference

9 December 2017

3029-3043

1 reference

9 December 2017

24

1 reference

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

9 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Why the epidermal growth factor receptor? The rationale for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Tyrosine kinases as targets in cancer therapy - successes and failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Severe acute interstitial pneumonia and gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Gene-expression profiles predict survival of patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH331

21 January 2018

Identifiers

DOI

10.1093/HMG/DDH331

1 reference

release_adro5ncehvfmldafzhau7g7yoa

9 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/adro5ncehvfmldafzhau7g7yoa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference